Introduction
Rheumatic heart disease is a chronic condition in which the heart valves are damaged after an episode of rheumatic fever, an inflammatory illness that follows infection with group A streptococcal bacteria. The disease primarily affects the heart valves, especially the mitral valve and, less often, the aortic valve. It develops because the immune response to the earlier infection mistakenly injures heart tissue, leading over time to scarring, thickening, and distortion of the valve structures that regulate blood flow through the heart.
The defining process in rheumatic heart disease is not the bacterial infection itself, but the body’s abnormal immune reaction to that infection. In susceptible individuals, the immune system attacks tissues that resemble streptococcal components, producing inflammation in the heart, joints, skin, and nervous system during the acute phase of rheumatic fever. When this inflammatory process involves the heart valves, it can leave permanent structural changes that interfere with normal circulation.
The Body Structures or Systems Involved
The main structures affected in rheumatic heart disease are the cardiac valves, the thin but strong leaflets that open and close with each heartbeat to keep blood moving in the correct direction. The mitral valve lies between the left atrium and left ventricle, and the aortic valve sits between the left ventricle and the aorta. In health, these valves open widely when blood needs to pass forward and close tightly to prevent backward flow.
The valve leaflets are supported by chordae tendineae and papillary muscles, which help maintain proper closure under pressure. The endocardium, the smooth inner lining of the heart, is also involved because inflammation begins on or near these surfaces. The myocardium may be affected during acute rheumatic fever, but the lasting problem in rheumatic heart disease is usually valve injury rather than primary damage to the pumping muscle.
The immune and inflammatory systems are central to the disease process. White blood cells, antibodies, and inflammatory signaling molecules contribute to tissue damage after streptococcal infection. Blood circulation is affected indirectly because valve dysfunction alters the pressure and flow patterns through the chambers of the heart and into the systemic circulation.
How the Condition Develops
Rheumatic heart disease begins with a throat or, less commonly, skin infection caused by group A Streptococcus. In some people, usually children or adolescents, the immune system responds to this infection in a way that later becomes misdirected against the body’s own tissues. This phenomenon is known as molecular mimicry. Certain streptococcal proteins resemble proteins found in human heart tissue, particularly in the valves and cardiac connective tissue. As a result, antibodies and T cells generated to fight the bacteria may also bind to host tissue.
This misdirected immune response triggers acute rheumatic fever, an inflammatory syndrome that may involve the heart, joints, skin, and brain. When the heart is affected, inflammation can occur in the endocardium and valvular tissue. Repeated or severe episodes of inflammation injure the delicate valve leaflets. The tissue responds by healing, but healing in this setting is not normal restoration. Instead, it produces fibrosis, thickening, and fusion of valve edges and supporting structures.
Over time, these structural changes cause the valve to open less efficiently or close improperly. The mitral valve is most often damaged because its structure and blood-flow dynamics make it particularly vulnerable. If the valve becomes narrowed, blood has difficulty moving from the left atrium into the left ventricle. If it becomes leaky, blood flows backward when the ventricle contracts. Either pattern disrupts the normal pressure relationships within the heart.
The progression from infection to chronic heart disease usually occurs over years. The initial streptococcal infection is followed by an immune reaction, then by repeated inflammatory injury or persistent valve inflammation, and finally by permanent remodeling of the valves and surrounding tissue. The chronic disease is therefore the end result of both immune-mediated damage and the body’s attempt to repair that damage.
Structural or Functional Changes Caused by the Condition
The most important changes in rheumatic heart disease are thickening, scarring, and deformity of the heart valves. Valve leaflets may become stiff and less mobile, commissures may fuse, and chordae tendineae may shorten or thicken. These changes reduce the valve’s ability to move freely and maintain a tight seal. The classic anatomic appearance of advanced rheumatic valve disease is a distorted valve with narrowed openings and remodeled supporting tissue.
Functionally, these structural changes lead to two main problems: stenosis and regurgitation. Stenosis means the valve opening is too narrow, so blood must move through a smaller space than normal. This increases pressure in the chamber behind the valve and can alter blood flow through the lungs or the rest of the body. Regurgitation means the valve fails to close fully, allowing blood to leak backward. That forces the heart to work harder because the same blood is pumped more than once.
Inflammation during the active phase of disease can also make the valves swollen and less efficient before permanent scarring appears. In chronic disease, the major effect is mechanical: altered valve geometry changes intracardiac pressures, chamber loading conditions, and the efficiency of each heartbeat. The heart may respond by enlarging chambers, thickening muscle, or increasing filling pressures, but these adaptations can only partly compensate for the damaged valve.
Because the mitral valve is commonly involved, pressure can build up in the left atrium and backward into the pulmonary veins, affecting blood flow through the lungs. If the aortic valve is involved, the left ventricle may face abnormal volume load or pressure load depending on the type of valve dysfunction. These changes are physical and hemodynamic, not merely inflammatory, and they define the long-term burden of the disease.
Factors That Influence the Development of the Condition
The key trigger for rheumatic heart disease is untreated or inadequately treated streptococcal infection, especially recurrent infections of the throat. The risk increases when exposure to the bacteria is repeated, since each episode can provoke another immune response and another opportunity for valve injury. Not every streptococcal infection leads to rheumatic fever, which indicates that host susceptibility plays an important role.
Genetic factors influence how the immune system recognizes streptococcal antigens and how strongly it responds. Some individuals appear to mount immune responses that are more likely to cross-react with cardiac tissue. The exact genetic contributors are complex and involve multiple immune-regulatory pathways rather than a single mutation. Family clustering and population differences support the idea that inherited susceptibility affects risk.
Age also matters. Rheumatic fever and the later development of rheumatic heart disease most often begin in childhood or adolescence, when streptococcal throat infections are common and immune responses are still developing. Environmental factors such as crowded living conditions can increase the spread of streptococcal bacteria, raising the likelihood of repeated infection. Limited access to timely diagnosis and antibiotic treatment allows the initial immune-triggering event to persist long enough for rheumatic fever to occur.
The intensity and duration of the immune response influence how much damage is done. Stronger inflammation, recurrent attacks, and involvement of the heart during acute rheumatic fever all increase the probability of permanent valve scarring. The disease is therefore shaped by the interaction of infection, immune behavior, and repeated tissue injury rather than by a single isolated event.
Variations or Forms of the Condition
Rheumatic heart disease can range from subtle valve injury to severe multi-valve disease. In mild forms, the damage may be limited and produce little distortion of valve structure. In more advanced cases, the valve leaflets are markedly thickened, the commissures are fused, and the chordae are shortened, creating significant obstruction or leakage. The functional impact depends on which valve is affected and whether stenosis, regurgitation, or both are present.
The disease may also be single-valve or multi-valve. The mitral valve is most frequently affected alone, but the aortic valve can also be involved, and combined lesions are common in more advanced disease. The pattern of involvement reflects differences in tissue vulnerability and hemodynamic stress across the valves.
Another important distinction is between the acute inflammatory phase and the chronic scarred phase. In the acute phase, the valves and surrounding cardiac tissues may be inflamed but not yet permanently deformed. In the chronic phase, inflammation has given way to fibrosis and structural remodeling. The chronic stage is what generally defines rheumatic heart disease as a lasting cardiac disorder.
There is also variation in the type of valve dysfunction. Some valves become predominantly stenotic, others predominantly regurgitant, and many develop mixed disease. These forms arise from different combinations of leaflet thickening, edge fusion, calcification, and chordal shortening. The specific anatomy determines how blood flow is altered and how the heart compensates.
How the Condition Affects the Body Over Time
Over time, persistent rheumatic heart disease can place chronic strain on the heart’s chambers and on the circulation as a whole. A narrowed or leaking valve forces the heart to generate higher pressures or handle larger volumes of blood than normal. The chambers upstream from the damaged valve may enlarge in response, and the heart muscle may undergo remodeling to preserve output. These compensatory changes can sustain function for a period, but they also increase the risk of further cardiac dysfunction if the valve disease progresses.
The left atrium often enlarges when the mitral valve is affected because it must work against increased resistance or manage recurrent backward flow. This enlargement changes the electrical and mechanical behavior of the atrium and can alter filling dynamics across the heart. In more advanced disease, pressure may back up into the pulmonary circulation, affecting gas exchange and vascular pressures in the lungs. If the aortic valve is involved, the left ventricle may face increased workload and progressive remodeling.
Chronic valve distortion does not remain static in all cases. Ongoing mechanical stress on already damaged tissue can worsen leakage or narrowing, especially if inflammation has recurred. Calcification may develop in scarred valves, making them even stiffer and less functional. Over years, the disease can produce significant structural remodeling of the heart even when the original streptococcal infection is long gone.
The body’s response to chronic hemodynamic stress is adaptive at first but eventually becomes maladaptive. Chamber enlargement, changes in wall thickness, and altered pressure relationships help maintain circulation temporarily, yet these same changes can reduce efficiency and make the heart more vulnerable to rhythm disturbances and pump failure. Rheumatic heart disease is therefore a progressive structural disorder whose long-term effects arise from the lasting consequences of immune-mediated valve injury.
Conclusion
Rheumatic heart disease is a chronic valve disorder caused by immune-mediated injury after streptococcal infection and rheumatic fever. Its core features are inflammation, scarring, and remodeling of the heart valves, especially the mitral valve, leading to stenosis, regurgitation, or both. The disease develops through molecular mimicry, in which the immune system damages cardiac tissue while targeting bacterial antigens.
Understanding rheumatic heart disease requires following the sequence from infection to immune activation, tissue inflammation, healing by fibrosis, and finally permanent changes in valve structure and blood flow. The condition is defined less by the original infection than by the body’s response to it. That response leaves mechanical consequences in the heart, making rheumatic heart disease a disorder of both immunology and cardiac anatomy.